Gerard Vreugdenhil
- Oncology top 0.5%
- Hematology top 1%
- Pulmonary and Respiratory Medicine top 5%
- Pathology and Forensic Medicine top 2%
- Dermatology top 0.5%
- Co-authors
- Floortje MolsLonneke V. van de Poll‐FranseAntoinetta J. M. BeijersJ.W.W. CoeberghA. J. G. SwaakH.G. van EijkV.E.P.P. LemmensGoof Schep
- Topics
- Cancer Treatment and Pharmacology (37 papers)Cancer Immunotherapy and Biomarkers (20 papers)Cancer survivorship and care (20 papers)
- Cited by
- OncologyHematologyDermatology
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Gerard Vreugdenhil
156 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 133
- Oncology 3.2k
- Hematology 917
- Pulmonary and Respiratory Medicine 753
- Pathology and Forensic Medicine 660
- Dermatology 655
Countries citing papers authored by Gerard Vreugdenhil
This map shows the geographic impact of Gerard Vreugdenhil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Vreugdenhil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Vreugdenhil more than expected).
Fields of papers citing papers by Gerard Vreugdenhil
This network shows the impact of papers produced by Gerard Vreugdenhil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Vreugdenhil. The network helps show where Gerard Vreugdenhil may publish in the future.
Co-authorship network of co-authors of Gerard Vreugdenhil
This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Vreugdenhil. A scholar is included among the top collaborators of Gerard Vreugdenhil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Vreugdenhil. Gerard Vreugdenhil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 8 | |
| 8 | 3 | |
| 9 | 18 | |
| 10 | 32 | |
| 11 | 37 | |
| 12 | 62 | |
| 13 | 37 | |
| 14 | 9 | |
| 15 | Chemotherapie-geïnduceerde perifere neuropathie. Invloed op kwaliteit van leven | 0 |
| 16 | 109 | |
| 17 | CBO-richtlijn 'behandeling van het mammacarcinoom' | 38 |
| 18 | [Impact of the new guidelines for adjuvant systemic treatment of breast cancer at hospital level]. | 2 |
| 19 | 33 | |
| 20 | Efficacy amd tolerance of long-term treatment with granulocyte-macrophage-colony-stimulating factor in allogeneic bone-marrow transplantation recipients | 3 |
About Gerard Vreugdenhil
Gerard Vreugdenhil is a scholar working on Oncology, Hematology and Dermatology, having authored 165 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (37 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cancer survivorship and care (20 papers). The work is most often cited by research in Oncology (3.2k citations), Hematology (917 citations) and Dermatology (655 citations). Gerard Vreugdenhil has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Floortje Mols, Lonneke V. van de Poll‐Franse, Antoinetta J. M. Beijers, J.W.W. Coebergh, A. J. G. Swaak, H.G. van Eijk, V.E.P.P. Lemmens, Goof Schep, Adri C. Voogd and A.J.J.M. Vingerhoets. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.